SCHEMBL371130

SCHEMBL371130

Cc1ccccc1C(CC(=NO)c1ccc(=O)n(C)c1)c1ccc(-c2ccc(CCC(=O)O)cc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GPBAR1 Q8TDU6 5/20 0.51
FFAR1 O14842 7/20 0.39
FFAR4 Q5NUL3 2/20 0.34
CHRM2 P08172 1/20 0.34
S1PR1 P21453 1/20 0.34
FPR1 P21462 1/20 0.34
FPR3 P25089 1/20 0.34
GPR183 P32249 1/20 0.34
APLNR P35414 1/20 0.34
GPR65 Q8IYL9 1/20 0.34
MME P08473 1/20 0.34
ITGB1 P05556 1/20 0.34
ITGA4 P13612 1/20 0.34
BRD4 O60885 1/20 0.34
LMNA P02545 1/20 0.33
TAAR1 Q96RJ0 1/20 0.33
MMP12 P39900 2/20 0.33
MMP13 P45452 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL371129 1.00 GPBAR1 (0.51) GPBAR1FFAR1FFAR4CHRM2S1PR1
SCHEMBL1389800 0.89 GPBAR1 (0.64) GPBAR1BRD4LMNA
SCHEMBL1389804 0.89 GPBAR1 (0.64) GPBAR1BRD4LMNA
SCHEMBL1389797 0.89 GPBAR1 (0.64) GPBAR1BRD4LMNA
SCHEMBL1389808 0.89 GPBAR1 (0.64) GPBAR1BRD4LMNA
SCHEMBL371106 0.89 GPBAR1 (0.64) GPBAR1BRD4LMNA
SCHEMBL1389586 0.89 GPBAR1 (0.64) GPBAR1BRD4LMNA
SCHEMBL1389584 0.89 GPBAR1 (0.64) GPBAR1BRD4LMNA
SCHEMBL1389893 0.88 GPBAR1 (0.52) GPBAR1FFAR1ITGB1ITGA4BRD4
SCHEMBL1389895 0.88 GPBAR1 (0.52) GPBAR1FFAR1ITGB1ITGA4BRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2593426-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F.HOFFMANN-LA ROCHE AG (CH) 2013-05-22 EP claimed
WO-2012007365-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-19 WO claimed
EP-2593426-B1 1-HYDROXYIMINO-3-PHENYL-PROPANES HOFFMANN LA ROCHE (CH) 2014-08-20 EP disclosed
US-8765730-B2 1-hydroxyimino-3-phenyl-propanes Hoffmann-La Roche Inc (US) 2014-07-01 US disclosed
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES GPBAR1, GPR119, ADRB1 GPBAR1 1/4885FFAR1 14/4885FFAR4 102/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.